Affinity Asset Advisors, LLC Q4 2022 Filing
Filed February 13, 2023
Portfolio Value
$255.0T
Holdings
60
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (60 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | 290ACHINOOK THERAPEUTICS INC | 818,035 | $21.4T | 8.41% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 70,000 | $20.3T | 7.97% | |
| 3 | BMYBRISTOL MYERS SQUIBB CO | 175,000 | $12.6T | 4.94% | Put |
| 4 | ESTAESTABLISHMENT LABS HLDGS INC | 190,767 | $12.5T | 4.91% | |
| 5 | VRNAVERONA PHARMA PLC | 417,498 | $10.9T | 4.28% | Call |
| 6 | ASNDASCENDIS PHARMA A S | 70,997 | $8.7T | 3.40% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 80,000 | $8.3T | 3.25% | |
| 8 | —PROMETHEUS BIOSCIENCES INC | 75,000 | $8.3T | 3.24% | |
| 9 | VTYXVENTYX BIOSCIENCES INC | 240,623 | $7.9T | 3.09% | |
| 10 | MORFMORPHIC HLDG INC | 280,921 | $7.5T | 2.95% | |
| 11 | ACLXARCELLX INC | 240,143 | $7.4T | 2.92% | |
| 12 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,143,531 | $7.2T | 2.81% | |
| 13 | CATBUSDASTRIA THERAPEUTICS INC | 472,482 | $7.0T | 2.76% | |
| 14 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 215,000 | $6.8T | 2.66% | |
| 15 | NARIUSDINARI MED INC | 90,000 | $5.7T | 2.24% | |
| 16 | VKTXVIKING THERAPEUTICS INC | 600,000 | $5.6T | 2.21% | Call |
| 17 | MRNAMODERNA INC | 30,000 | $5.4T | 2.11% | Put |
| 18 | AMGNAMGEN INC | 20,000 | $5.3T | 2.06% | Put |
| 19 | HZNPHORIZON THERAPEUTICS PUB L | 45,000 | $5.1T | 2.01% | |
| 20 | RCKTROCKET PHARMACEUTICALS INC | 258,115 | $5.1T | 1.98% | |
| 21 | TCE2CELLDEX THERAPEUTICS INC NEW | 110,000 | $4.9T | 1.92% | |
| 22 | BLUBELLUS HEALTH INC NEW | 573,678 | $4.7T | 1.85% | |
| 23 | GONGERON CORP | 1,893,500 | $4.6T | 1.80% | Put |
| 24 | AZNASTRAZENECA PLC | 60,000 | $4.1T | 1.60% | |
| 25 | CYTKCYTOKINETICS INC | 87,601 | $4.0T | 1.57% | |
| 26 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 10,000,000 | $3.9T | 1.53% | |
| 27 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $3.4T | 1.34% | |
| 28 | KURAKURA ONCOLOGY INC | 268,747 | $3.3T | 1.31% | |
| 29 | LNTHLANTHEUS HLDGS INC | 60,630 | $3.1T | 1.21% | |
| 30 | PCVXVAXCYTE INC | 60,000 | $2.9T | 1.13% | |
| 31 | SNDXSYNDAX PHARMACEUTICALS INC | 100,000 | $2.5T | 1.00% | |
| 32 | IOVAIOVANCE BIOTHERAPEUTICS INC | 375,000 | $2.4T | 0.94% | |
| 33 | KPTIEURKARYOPHARM THERAPEUTICS INC | 661,264 | $2.2T | 0.88% | |
| 34 | COGTCOGENT BIOSCIENCES INC | 193,064 | $2.2T | 0.88% | |
| 35 | —POINT BIOPHARMA GLOBAL INC | 303,218 | $2.2T | 0.87% | |
| 36 | NVV1NOVAVAX INC | 200,000 | $2.1T | 0.81% | Put |
| 37 | XENEXENON PHARMACEUTICALS INC | 50,000 | $2.0T | 0.77% | |
| 38 | ARGXARGENX SE | 5,000 | $1.9T | 0.74% | |
| 39 | NVCRNOVOCURE LTD | 25,000 | $1.8T | 0.72% | Call |
| 40 | NVLSEURALPINE IMMUNE SCIENCES INC | 247,891 | $1.8T | 0.71% | |
| 41 | —VINCERX PHARMA INC | 1,492,771 | $1.5T | 0.60% | |
| 42 | —PRECIGEN INC | 1,500,000 | $1.5T | 0.58% | |
| 43 | CNTACENTESSA PHARMACEUTICALS PLC | 460,328 | $1.4T | 0.56% | |
| 44 | ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE | 2,500,000 | $1.4T | 0.53% | |
| 45 | KALVKALVISTA PHARMACEUTICALS INC | 188,292 | $1.3T | 0.50% | |
| 46 | BCABBIOATLA INC | 150,000 | $1.2T | 0.49% | |
| 47 | DYNDYNE THERAPEUTICS INC | 92,170 | $1.1T | 0.42% | |
| 48 | LIANYLIANBIO | 650,000 | $1.1T | 0.42% | |
| 49 | NRIXNURIX THERAPEUTICS INC | 80,000 | $878.4B | 0.34% | |
| 50 | MIRMMIRUM PHARMACEUTICALS INC | 40,000 | $780.0B | 0.31% | |
| 51 | FHTXFOGHORN THERAPEUTICS INC | 109,991 | $701.7B | 0.28% | |
| 52 | SGENUSDSEAGEN INC | 5,000 | $642.5B | 0.25% | |
| 53 | CNTXCONTEXT THERAPEUTICS INC | 883,654 | $583.7B | 0.23% | |
| 54 | INZYINOZYME PHARMA INC | 500,000 | $525.0B | 0.21% | |
| 55 | NUVBNUVATION BIO INC | 250,000 | $480.0B | 0.19% | |
| 56 | IMTXIMMATICS N.V | 187,204 | $469.9B | 0.18% | |
| 57 | MISTMILESTONE PHARMACEUTICALS IN | 100,000 | $396.0B | 0.16% | |
| 58 | SCLXWSCILEX HOLDING CO | 18,099 | $3.4B | 0.00% | |
| 59 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $2.9B | 0.00% | |
| 60 | SCLXUSDSCILEX HOLDING CO | 463 | $1.8B | 0.00% |